MedTrace Logo

Diaphragmatic Breathing Exercises on Sleep Disorders un Polycystic Ovarian Syndrome

NCT07698925 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-07-14

No results posted yet for this study

Summary

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in females in reproductive age and not completely understood. Women with PCOS appear to have an increased frequency of sleep problems. Diaphragmatic Breathing (DB) exercises has positive effects on improving sleep quality. The purpose of this study will evaluate the effect of diaphragmatic breathing exercises on improving sleep quality in polycystic ovarian syndrome women.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Pittsburg Sleep Quality Index
  • Fatigue Severity Scale
  • Insomnia Severity Index
  • Diaphragmatic Breathing Exercise
  • Sleep Disorders

Interventions

OTHER

Diaphragmatic breathing exercises

Its course is 3 times per week, 6 minutes twice a day, for 8 weeks. When it's the first time to learn how to perform the diaphragmatic breathing technique, it's easier to follow the instructions lying down in supine position with a pillow under head. The patient will be asked to place one hand on her abdomen, just below her ribcage, and the other hand on the middle of her chest to become aware of her diaphragm's position and function during breathing. She will be told to breathe slowly and deeply through her nose and let her abdomen rise as much as possible. The length of the inhalation or exhalation should be 2-3 seconds

OTHER

Lifestyle modification advices

Avoid caffeine, smoking, alcohol, napping; thirsty or hungry Regular exercising, sleep timing, relax techniques; Reduce noise, Ensure bedroom clean, no TV, mobile in bed, snack near bed, warm bath pre sleep, wear sleep cloths, most relaxed position for sleep.

Sponsors & Collaborators

  • Adly A Adam

    lead OTHER

Principal Investigators

  • Soheir M Elkosery, Professor · Cairo University; Faculty of Physical Therapy

  • Ahmed M Othman, Professor · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-11
Primary Completion
2026-09-01
Completion
2026-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698925 on ClinicalTrials.gov